P002 Annual Business Meeting and Plenary
DESCRIPTION
During the Annual Business Meeting, hear from the AAD/A’s president Murad Alam, MD, MSCI, MBA, FAAD and Secretary-Treasurer Keyvan Nouri, MD, FAAD about the AAD/As state of affairs.
INFORMAL DISCUSSION OF ISSUES OF IMPORTANCE FROM THE FLOOR*
Pursuant to the Administrative Regulation of the American Academy of Dermatology and the American Academy of Dermatology Association, during any debate at a membership meeting each speaker must introduce themselves by name and professional position. He or she must also identify any potential conflicts of interest. *No CME Credit.
The plenary session offers attendees the opportunity to hear from renowned experts on topics that impact dermatologists today. Speakers include Academy leadership and award-winning named lecturers.
LEARNING OBJECTIVES
Discuss remarkable changes in health care concerns and changes in educational delivery tools.
DIRECTOR
Howard Wooding Rogers, MD, PhD, FAAD
SPEAKERS
Nada Elbuluk, MSc, MD, FAAD
University of Southern California, Keck School of Medicine
William D. James, MD, FAAD
Department of Dermatology, University of Pennsylvania School of Medicine
Youn H. Kim, MD, FAAD
DISCLOSURES
Nada Elbuluk, MSc, MD, FAAD
AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); SkinCeuticals LLC – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); The Skin of Color Society – Board of Directors(No Compensation Received); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VisualDx – Consultant(Stock Options);
William D. James, MD, FAAD
Elsevier Inc. – Other(Other Financial Benefit); WebMD – Other(Honoraria);
Youn H. Kim, MD, FAAD
CRISPR Therapeutics – Investigator(Grants/Research Funding); Dren Bio, Inc – Investigator(Grants/Research Funding), Other(No Compensation Received); Innate Pharma S.A. – Other(No Compensation Received); Innate Pharma, S.A. – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LIBO Pharma Corp. – Advisory Board(Honoraria); ONO-Pharma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Secura Bio – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Speaker(Honoraria); Treeline – Investigator(Grants/Research Funding);
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);